{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:15:35Z","timestamp":1768810535644,"version":"3.49.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["183193"],"award-info":[{"award-number":["183193"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K19394"],"award-info":[{"award-number":["18K19394"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03458"],"award-info":[{"award-number":["19H03458"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K06655"],"award-info":[{"award-number":["18K06655"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hepatocyte infection by malaria sporozoites is a bottleneck in the life-cycle of <jats:italic>Plasmodium<\/jats:italic> spp. including <jats:italic>P. falciparum<\/jats:italic>, which causes the most lethal form of malaria. Therefore, developing an effective vaccine capable of inducing the strong humoral and cellular immune responses necessary to block the pre-erythrocytic stage has potential to overcome the spatiotemporal hindrances pertaining to parasite biology and hepatic microanatomy. We recently showed that when combined with a human adenovirus type 5 (AdHu5)-priming vaccine, adeno-associated virus serotype 1 (AAV1) is a potent booster malaria vaccine vector capable of inducing strong and long-lasting protective immune responses in a rodent malaria model. Here, we evaluated the protective efficacy of a hepatotropic virus, adeno-associated virus serotype 8 (AAV8), as a booster vector because it can deliver a transgene potently and rapidly to the liver, the organ malaria sporozoites initially infect and multiply in following sporozoite injection by the bite of an infected mosquito. We first generated an AAV8-vectored vaccine expressing <jats:italic>P. falciparum<\/jats:italic> circumsporozoite protein (PfCSP). Intravenous (i.v.) administration of AAV8-PfCSP to mice initially primed with AdHu5-PfCSP resulted in a hepatocyte transduction rate ~2.5 times above that seen with intramuscular (i.m.) administration. This immunization regimen provided a better protection rate (100% sterile protection) than that of the i.m. AdHu5-prime\/i.m. AAV8-boost regimen (60%, <jats:italic>p<\/jats:italic> &amp;lt; 0.05), i.m. AdHu5-prime\/i.v. AAV1-boost (78%), or i.m. AdHu5-prime\/i.m. AAV1-boost (80%) against challenge with transgenic PfCSP-expressing <jats:italic>P. berghei<\/jats:italic> sporozoites. Compared with the i.m. AdHu5-prime\/i.v. AAV1-boost regimen, three other regimens induced higher levels of PfCSP-specific humoral immune responses. Importantly, a single i.v. dose of AAV8-PfCSP recruited CD8<jats:sup>+<\/jats:sup> T cells, especially resident memory CD8<jats:sup>+<\/jats:sup> T cells, in the liver. These data suggest that boost with i.v. AAV8-PfCSP can improve humoral and cellular immune responses in BALB\/c mice. Therefore, this regimen holds great promise as a next-generation platform for the development of an effective malaria vaccine.<\/jats:p>","DOI":"10.3389\/fimmu.2021.612910","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T07:14:16Z","timestamp":1624432456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Liver-Directed AAV8 Booster Vaccine Expressing Plasmodium falciparum Antigen Following Adenovirus Vaccine Priming Elicits Sterile Protection in a Murine Model"],"prefix":"10.3389","volume":"12","author":[{"given":"Mohammad","family":"Shahnaij","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Iyori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Kajino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iroha","family":"Yamagoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intan","family":"Syafira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yenni","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke S.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotomo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1001685","DOI":"10.1371\/journal.pmed.1001685","article-title":"Efficacy and Safety of the RTS,S\/AS01 Malaria Vaccine During 18 Months After Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites","volume":"11","year":"2014","journal-title":"PLoS Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and Safety of RTS,S\/AS01 Malaria Vaccine With or Without a Booster Dose in Infants and Children in Africa: Final Results of a Phase 3, Individually Randomised, Controlled Trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap9128","article-title":"Prime and Target Immunization Protects Against Liver-Stage Malaria in Mice","volume":"10","author":"Gola","year":"2018","journal-title":"Sci Transl Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.coi.2016.05.014","article-title":"Viral Vectors as Vaccine Platforms: From Immunogenicity to Impact","volume":"41","author":"Ewer","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00005","article-title":"AAV Vectors Vaccines Against Infectious Diseases","volume":"5","author":"Nieto","year":"2014","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00730","article-title":"Adeno-Associated Virus As An Effective Malaria Booster Vaccine Following Adenovirus Priming","volume":"10","author":"Yusuf","year":"2019","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02412","article-title":"A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies","volume":"10","author":"Yusuf","year":"2019","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107453","article-title":"Adeno-Associated Viral Vector-Mediated Immune Responses: Understanding Barriers to Gene Delivery","volume":"207","author":"Nidetz","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.2.948","article-title":"Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection Against SARS-CoV Infection","volume":"180","author":"Du","year":"2008","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/10430340260201662","article-title":"Oral Administration of Recombinant Adeno-Associated Virus Elicits Human Immunodeficiency Virus-Specific Immune Responses","volume":"13","author":"Xin","year":"2002","journal-title":"Hum Gene Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/104303401750214276","article-title":"A Novel Recombinant Adeno-Associated Virus Vaccine Induces a Long-Term Humoral Immune Response to Human Immunodeficiency Virus","volume":"12","author":"Xin","year":"2001","journal-title":"Hum Gene Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e29428","DOI":"10.1371\/journal.pone.0029428","article-title":"A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity","volume":"6","author":"Goodman","year":"2011","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e70819","DOI":"10.1371\/journal.pone.0070819","article-title":"Protective Efficacy of Baculovirus Dual Expression System Vaccine Expressing Plasmodium Falciparum Circumsporozoite Protein","volume":"8","author":"Iyori","year":"2013","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12936-017-2039-x","article-title":"DAF-Shielded Baculovirus-Vectored Vaccine Enhances Protection Against Malaria Sporozoite Challenge in Mice","volume":"16","author":"Iyori","year":"2017","journal-title":"Malar J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1038\/s41598-018-21369-y","article-title":"Adenovirus-Prime and Baculovirus-Boost Heterologous Immunization Achieves Sterile Protection Against Malaria Sporozoite Challenge in a Murine Model","volume":"8","author":"Yoshida","year":"2018","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/imb.12055","article-title":"Visualization and Live Imaging Analysis of a Mosquito Saliva Protein in Host Animal Skin Using a Transgenic Mosquito With a Secreted Luciferase Reporter System","volume":"22","author":"Yamamoto","year":"2013","journal-title":"Insect Mol Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/hgtb.2015.013","article-title":"Systematic Comparison and Validation of Quantitative Real-Time PCR Methods for the Quantitation of Adeno-Associated Viral Products","volume":"26","author":"Werling","year":"2015","journal-title":"Hum Gene Ther Methods"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis699","article-title":"Protection Against Henipavirus Infection by Use of Recombinant Adeno-Associated Virus-Vector Vaccines","volume":"207","author":"Ploquin","year":"2013","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.1.214-224.2005","article-title":"Unrestricted Hepatocyte Transduction With Adeno-Associated Virus Serotype 8 Vectors in Mice","volume":"79","author":"Nakai","year":"2005","journal-title":"J Virol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-59745-210-6_2","article-title":"The Role of the Adeno-Associated Virus Capsid in Gene Transfer","volume":"437","author":"Van Vliet","year":"2008","journal-title":"Methods Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV Serotypes 1-9 Mediated Gene Expression and Tropism in Mice After Systemic Injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix644","article-title":"Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice","volume":"217","author":"van Lieshout","year":"2018","journal-title":"J\u00a0Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1406674111","article-title":"Antigen Expression Level Threshold Tunes the Fate of CD8 T Cells During Primary Hepatic Immune Responses","volume":"111","author":"Tay","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1254536","article-title":"Resident Memory CD8 T Cells Trigger Protective Innate and Adaptive Immune Responses","volume":"346","author":"Schenkel","year":"2014","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature10339","article-title":"Different Patterns of Peripheral Migration by Memory CD4+ and CD8+ T Cells","volume":"477","author":"Gebhardt","year":"2011","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.107","article-title":"Profiling the Host Response to Malaria Vaccination and Malaria Challenge","volume":"33","author":"Dunachie","year":"2015","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nri3169","article-title":"Living in the Liver: Hepatic Infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00239-X","article-title":"Immunogenicity of the RTS,S\/AS01 Malaria Vaccine and Implications for Duration of Vaccine Efficacy: Secondary Analysis of Data From a Phase 3 Randomised Controlled Trial","volume":"15","author":"White","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-Cell Immunity to Human Malaria Induced by Chimpanzee adenovirus-MVA Immunisation","volume":"4","author":"Ewer","year":"2013","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb4757","article-title":"Mapping Functional Humoral Correlates of Protection Against Malaria Challenge Following RTS,S\/AS01 Vaccination","volume":"12","author":"Suscovich","year":"2020","journal-title":"Sci Transl Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00878-06","article-title":"The 37\/67-Kilodalton Laminin Receptor is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9","volume":"80","author":"Akache","year":"2006","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","article-title":"Liver-Resident Memory CD8+ T Cells Form a Front-Line Defense Against Malaria Liver-Stage Infection","volume":"45","author":"Fernandez-Ruiz","year":"2016","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-370-7_6","article-title":"AAV-Mediated Liver-Directed Gene Therapy","volume":"807","author":"Sands","year":"2011","journal-title":"Methods Mol Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1211548","article-title":"Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu281","article-title":"The Chemokine Receptor CXCR6 is Required for the Maintenance of Liver Memory CD8+ T Cells Specific for Infectious Pathogens","volume":"210","author":"Tse","year":"2014","journal-title":"J Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.celrep.2018.08.094","article-title":"CD8+ T Cell Activation Leads to Constitutive Formation of Liver Tissue-Resident Memory T Cells That Seed a Large and Flexible Niche in the Liver","volume":"25","author":"Holz","year":"2018","journal-title":"Cell Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2988","article-title":"Therapeutic In Vivo Gene Transfer for Genetic Disease Using AAV: Progress and Challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat Rev Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.048","article-title":"Malaria Vaccines: Focus on Adenovirus Based Vectors","volume":"30","author":"Schuldt","year":"2012","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2018.02.003","article-title":"Influence of Pre-Existing Anti-Capsid Neutralizing and Binding Antibodies on AAV Vector Transduction","volume":"9","author":"Fitzpatrick","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.182412299","article-title":"Novel Adeno-Associated Viruses From Rhesus Monkeys as Vectors for Human Gene Therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum Gene Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.612910\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T07:14:20Z","timestamp":1624432460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.612910\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2021.612910"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.612910","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"article-number":"612910"}}